The economic impact and cost of visual impairment in Australia

British Journal of Ophthalmology

Volumn 90, Issue 3, 2006, Pages 272-275

  Taylor, Hugh R ^a,b   Pezzullo, M L ^c   Keeffe, J E ^a,b  

^a UNIVERSITY OF MELBOURNE   (Australia)

^b UNIVERSITY OF NEW SOUTH WALES   (Australia)

^c Access Economics Pty Limited   (Australia)

Author keywords

[No Author keywords available]

Indexed keywords

ARTICLE; AUSTRALIA; CONTROLLED STUDY; COST OF ILLNESS; DEPRESSION; DIABETES MELLITUS; HEALTH CARE COST; HUMAN; ISCHEMIC HEART DISEASE; PREVALENCE; PRIORITY JOURNAL; STROKE; VISUAL DISORDER; VISUAL IMPAIRMENT;

ADULT; AGED; AGED, 80 AND OVER; AUSTRALIA; COST OF ILLNESS; FEMALE; HEALTH CARE COSTS; HUMANS; MALE; MIDDLE AGED; PREVALENCE; QUALITY-ADJUSTED LIFE YEARS; VISION DISORDERS;

EID: 33644653948     PISSN: 00071161     EISSN: None     Source Type: Journal    
DOI: 10.1136/bjo.2005.080986     Document Type: Article

References (22)

1. Frick KD, Foster A. The magnitude and cost of global blindness: an increasing problem that can be alleviated. Am J Ophthalmol 2003;135:471-6.
2. World Health Organization. Global initiative for the elimination of avoidable blindness. Geneva: WHO, 1977.
3. Frick KD, Foster A, Bah M, et al. Analysis of costs and benefits of the Gambian Eye Care Program. Arch Ophthalmol 2005;123:239-43.
4. Taylor HR, Keeffe JE, Vu HTV, et al. Vision loss in Australia. Med J Aust 2005;182:565-8.
5. Australian Bureau of Statistics. National health survey 2001: summary of results. Canberra: Australian Bureau of Statistics, 2002.
6. Australian Bureau of Statistics. 2001 Census basic community profiles and snapshots. Canberra, Australian Bureau of Statistics, 2002 (available at www.abs.gov.au).
7. Access Economics. Clear insight: the economic impact and cost of vision loss in Australia. Melbourne:Eye Research Australia, 2004 (available at www.cera.org.au/new/clearinsight/clearinsight.html).
8. Mathers C, Penm R. Disease costing methodology used in the Disease Costs and Impact Study 1993-94 (Health and Welfare Series no 3). Canberra: Australian Institute of Health and Welfare, 1998:1-95.
9. Australian Institute of Health and Welfare. Health system expenditure on disease and injury in Australia, 2000-01 (Health and Welfare Expenditure Series no 19). Canberra: Australian Institute of Health and Welfare, 2004.
10. World Health Organization. International Classification of Diseases Ninth Revision, Volume 2. Geneva: WHO, 1978.
11. Australian Bureau of Statistics. Labour force, Australia. Canberra: Australian Bureau of Statistics, 2004.
12. Frisch J. Towards a disability allowance: offsetting the costs of disability-an analysis. Queensland: Physical Disability Council of Australia, 2001.
13. Chou S-L, Keeffe JE. Vision related personal costs for people with impaired vision in Australia (Abstract 1398/B209). Fort Lauderdale: The Association for Research in Vision and Ophthalmology (ARVO) Conference, 2004;(USA).
14. Mathers C, Vos T, Stevenson C. Burden of disease and injury in Australia. Canberra: Australian Institute of Health and Welfare, 1999.
15. Viscusi WK, Aldy JE. The value of a statistical life: a critical review of market estimates throughout the world (Discussion Paper No 392, 2002). Cambridge MA, Harvard Law School 2002 (available at www.law.harvard.edu/ programs/olin_center/).
16. Costello P, Minchin N. Budget paper No 2: Budget measures 2002-03, Australia, Commonwealth of Australia, 2003 (available at www.budget.gov.au/2002- 03/bp2/html/03_BP2Expense_3.html).
17. Livingston PM, McCarty CA, Taylor HR. Knowledge, attitudes and self care practices associated with age related eye disease in Australia. Br J Ophthalmol 1998;82:780-5.
18. The Vision Initiative. A plan for improving quality of life and health outcomes by reducing the impacts of vision impairment in our community. Melbourne: Vision 2020 Australia, 2002.
19. Busbee BG, Brown MM, Brown GC, et al. Cost-utility analysis of cataract surgery in the second eye. Ophthalmology 2003;110:2310-17.
20. Busbee BG, Brown MM, Brown GC, et al. Incremental cost-effectiveness of initial cataract surgery. Ophthalmology 2002;109:606-13.
21. Access Economics. Exceptional returns: the value of investing in health R&D in Australia. Melbourne: Australian Society for Medical Research, 2003.
22. Livingston PM. Visual impairment in Melbourne: prevalence and socio-economic risk factors (PhD Thesis). Melbourne: University of Melbourne, 1996.